Literature DB >> 10212121

Conformational and quantitative structure-activity relationship study of cytotoxic 2-arylidenebenzocycloalkanones.

J R Dimmock1, N M Kandepu, A J Nazarali, T P Kowalchuk, N Motaganahalli, J W Quail, P A Mykytiuk, G F Audette, L Prasad, P Perjési, T M Allen, C L Santos, J Szydlowski, E De Clercq, J Balzarini.   

Abstract

Various 2-arylideneindanones 1, 2-arylidenetetralones 2, and 2-arylidenebenzosuberones 3 were synthesized with the aim of determining the relative orientations of the two aryl rings which favored cytotoxicity. Molecular modeling of the unsubstituted compound in each series revealed differences in the spatial arrangements of the two aryl rings, and evaluation of these compounds against P388, L1210, Molt 4/C8, and CEM cells as well as a panel of human tumor cell lines indicated that in general the order of cytotoxicity was 3 > 2 > 1. In particular 2-(4-methoxyphenylmethylene)-1-benzosuberone (3k) had the greatest cytotoxicity, possessing 11 times the potency of the reference drug melphalan when all five screens were considered. Series 3 was considered in further detail. First, excision of the aryl ring fused to the cycloheptanone moiety in series 3 led to some 2-arylidene-1-cycloheptanones 4 which had approximately one-third of the bioactivity of the analogues 3. Second, in some screens cytotoxicity was correlated negatively with the sigma values and positively with the MR constants of the substituents in the arylidene aryl ring of 3. Third, X-ray crystallography of five representative compounds (3i,k-n) revealed differences in the locations of the aryl rings which may have contributed to the variations in cytotoxicity. Finally three members of series 3 inhibited RNA and protein syntheses and induced apoptosis in human Jurkat T cells. This study has revealed that 2-arylidene-1-benzosuberones are a group of useful cytotoxic agents, and in particular 3k serves as a prototypic molecule for subsequent structural modifications.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10212121     DOI: 10.1021/jm9806695

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Synthesis and biological evaluation of structurally diverse α-conformationally restricted chalcones and related analogues.

Authors:  Casey J Maguire; Graham J Carlson; Jacob W Ford; Tracy E Strecker; Ernest Hamel; Mary Lynn Trawick; Kevin G Pinney
Journal:  Medchemcomm       Date:  2019-06-04       Impact factor: 3.597

2.  1,3-diaryl-2-propenones and 2-benzylidene-1,3-indandiones: a quest for compounds displaying greater toxicity to neoplasms than normal cells.

Authors:  Hari N Pati; Umashankar Das; Hiroshi Sakagami; Masame Kawase; Qing Chu; Qintao Wang; James P Stables; Jonathan R Dimmock
Journal:  Arch Pharm (Weinheim)       Date:  2010-09       Impact factor: 3.751

3.  CLEFMA-an anti-proliferative curcuminoid from structure-activity relationship studies on 3,5-bis(benzylidene)-4-piperidones.

Authors:  Pallavi Lagisetty; Prachi Vilekar; Kaustuv Sahoo; Shrikant Anant; Vibhudutta Awasthi
Journal:  Bioorg Med Chem       Date:  2010-06-22       Impact factor: 3.641

4.  Effect of selected dimethylaminochalcones on some mitochondrial activities.

Authors:  Janka Vašková; Renáta Reisch; Ladislav Vaško; Martina Poškrobová; Ivan Kron; Juraj Guzy; Pál Perjési
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-04-19       Impact factor: 2.416

5.  Benzylidenetetralones, cyclic chalcone analogues, induce cell cycle arrest and apoptosis in HCT116 colorectal cancer cells.

Authors:  David Drutovic; Martina Chripkova; Martina Pilatova; Peter Kruzliak; Pal Perjesi; Marek Sarissky; Monica Lupi; Giovanna Damia; Massimo Broggini; Jan Mojzis
Journal:  Tumour Biol       Date:  2014-07-10

6.  Design, synthesis and antiproliferative activity of some 3-benzylidene-2,3-dihydro-1-benzopyran-4-ones which display selective toxicity for malignant cells.

Authors:  Pal Perjési; Umashankar Das; Erik De Clercq; Jan Balzarini; Masame Kawase; Hiroshi Sakagami; James P Stables; Tamas Lorand; Zsuzsanna Rozmer; Jonathan R Dimmock
Journal:  Eur J Med Chem       Date:  2007-07-10       Impact factor: 6.514

7.  Kinetic analysis of some chalcones and synthetic chalcone analogues on the fenton-reaction initiated deoxyribose degradation assay.

Authors:  Pál Perjési; Zsuzsanna Rozmer
Journal:  Open Med Chem J       Date:  2011-03-22

8.  (3E,5E)-1-Allyl-3,5-bis(4-meth-oxy-benzyl-idene)-piperidin-4-one.

Authors:  Abdulrahman I Almansour; Raju Suresh Kumar; Natarajan Arumugam; R Vishnupriya; J Suresh
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-06-12

9.  Synthesis and in vitro cytotoxic activity of novel chalcone-like agents.

Authors:  Bahram Letafat; Raheleh Shakeri; Saeed Emami; Saeedeh Noushini; Negar Mohammadhosseini; Nayyereh Shirkavand; Sussan Kabudanian Ardestani; Maliheh Safavi; Marjaneh Samadizadeh; Aida Letafat; Abbas Sha Ee; Alireza Foroumadi
Journal:  Iran J Basic Med Sci       Date:  2013-11       Impact factor: 2.699

10.  New chroman-4-one/thiochroman-4-one derivatives as potential anticancer agents.

Authors:  Seref Demirayak; Leyla Yurttas; Nalan Gundogdu-Karaburun; Ahmet Cagri Karaburun; Ismail Kayagil
Journal:  Saudi Pharm J       Date:  2017-04-26       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.